[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine

C102H97Cl4N19O2 — CID 161494496

IUPAC[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine
SMILESCN(C)C(=O)CNCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Cc1nnc2n1CCN(Cc1c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn13)C2.NC1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccncc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1
InChIInChI=1S/C27H26ClN5O.C26H23ClN6.C25H25ClN4.C24H23ClN4O/c28-23-6-3-20(4-7-23)26-24(33-17-22(19-1-2-19)5-8-25(33)30-26)18-31-13-15-32(16-14-31)27(34)21-9-11-29-12-10-21;1-18-29-30-25-17-31(13-14-32(18)25)16-23-26(20-7-10-22(27)11-8-20)28-24-12-9-21(15-33(23)24)19-5-3-2-4-6-19;26-21-9-6-19(7-10-21)25-23(17-29-14-12-22(27)13-15-29)30-16-20(8-11-24(30)28-25)18-4-2-1-3-5-18;1-28(2)23(30)15-26-14-21-24(18-8-11-20(25)12-9-18)27-22-13-10-19(16-29(21)22)17-6-4-3-5-7-17/h3-12,17,19H,1-2,13-16,18H2;2-12,15H,13-14,16-17H2,1H3;1-11,16,22H,12-15,17,27H2;3-13,16,26H,14-15H2,1-2H3
InChIKeyWGAFMBQUYJFQBJ-UHFFFAOYSA-N
MW1762.84 g/mol
LogP19.87
Rot. Bonds19

About [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine

[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine (PubChem CID 161494496) has the molecular formula C102H97Cl4N19O2 and a molecular weight of 1762.84 g/mol. Its IUPAC name is [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine.

Molecular Properties

Compound Name[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine
PubChem CID161494496
Molecular FormulaC102H97Cl4N19O2
Molecular Weight1762.84 g/mol
Exact Mass1759.68
IUPAC Name[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine
SMILESCN(C)C(=O)CNCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Cc1nnc2n1CCN(Cc1c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn13)C2.NC1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccncc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1
InChIInChI=1S/C27H26ClN5O.C26H23ClN6.C25H25ClN4.C24H23ClN4O/c28-23-6-3-20(4-7-23)26-24(33-17-22(19-1-2-19)5-8-25(33)30-26)18-31-13-15-32(16-14-31)27(34)21-9-11-29-12-10-21;1-18-29-30-25-17-31(13-14-32(18)25)16-23-26(20-7-10-22(27)11-8-20)28-24-12-9-21(15-33(23)24)19-5-3-2-4-6-19;26-21-9-6-19(7-10-21)25-23(17-29-14-12-22(27)13-15-29)30-16-20(8-11-24(30)28-25)18-4-2-1-3-5-18;1-28(2)23(30)15-26-14-21-24(18-8-11-20(25)12-9-18)27-22-13-10-19(16-29(21)22)17-6-4-3-5-7-17/h3-12,17,19H,1-2,13-16,18H2;2-12,15H,13-14,16-17H2,1H3;1-11,16,22H,12-15,17,27H2;3-13,16,26H,14-15H2,1-2H3
InChIKeyWGAFMBQUYJFQBJ-UHFFFAOYSA-N
XLogP19.87
TPSA201.19 Ų
H-Bond Donors2
H-Bond Acceptors19
Rotatable Bonds19
Heavy Atoms127
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001762.84
LogP ≤ 519.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1019

Analyze [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridazin-4-ylmethanone
CID 121309759
[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(1-methylpyrazol-4-yl)methanone
CID 121309789
[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone
CID 121309812
4-[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazine-1-carbonyl]benzonitrile
CID 121309937
[4-[[2-(4-chlorophenyl)-6-(1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone
CID 121309825
[4-[(2,6-diphenylimidazo[1,2-a]pyridin-3-yl)methyl]piperazin-1-yl]-(4-fluorophenyl)methanone
CID 83290300
[4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(2-methoxyphenyl)methanone
CID 121309682
[4-[[2-(4-chlorophenyl)-6-(3-ethoxyphenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(4-methoxyphenyl)methanone
CID 91635942
1-[1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-yl]-2-methoxyethanone
CID 121309686
(4-methylphenyl)-[4-[[2-(3-nitrophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]methanone
CID 83288876
[4-[[6-(3-ethoxyphenyl)-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-phenylmethanone
CID 83282490
[4-[[6-(4-chloro-2-methylphenyl)-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(3-fluorophenyl)methanone
CID 83276239

Frequently Asked Questions

What is the IUPAC name of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine?
The IUPAC name of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine (CID 161494496) is [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine.
What is the SMILES notation for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine?
The canonical SMILES for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine is CN(C)C(=O)CNCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Cc1nnc2n1CCN(Cc1c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn13)C2.NC1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4)cn23)CC1.O=C(c1ccncc1)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(C4CC4)cn23)CC1.
What is the InChIKey of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine?
The InChIKey is WGAFMBQUYJFQBJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26ClN5O.C26H23ClN6.C25H25ClN4.C24H23ClN4O/c28-23-6-3-20(4-7-23)26-24(33-17-22(19-1-2-19)5-8-25(33)30-26)18-31-13-15-32(16-14-31)27(34)21-9-11-29-12-10-21;1-18-29-30-25-17-31(13-14-32(18)25)16-23-26(20-7-10-22(27)11-8-20)28-24-12-9-21(15-33(23)24)19-5-3-2-4-6-19;26-21-9-6-19(7-10-21)25-23(17-29-14-12-22(27)13-15-29)30-16-20(8-11-24(30)28-25)18-4-2-1-3-5-18;1-28(2)23(30)15-26-14-21-24(18-8-11-20(25)12-9-18)27-22-13-10-19(16-29(21)22)17-6-4-3-5-7-17/h3-12,17,19H,1-2,13-16,18H2;2-12,15H,13-14,16-17H2,1H3;1-11,16,22H,12-15,17,27H2;3-13,16,26H,14-15H2,1-2H3.
What are the key properties of [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine?
[4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine has a molecular weight of 1762.84 g/mol, XLogP of 19.87, 19 rotatable bonds, 2 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[2-(4-chlorophenyl)-6-cyclopropylimidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-pyridin-4-ylmethanone;2-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methylamino]-N,N-dimethylacetamide;7-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]-3-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]piperidin-4-amine is sourced from PubChem (CID 161494496), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).